D-0571-2025 Class II Ongoing

Recalled by Cardinal Health Inc. — Dublin, OH

FDA drug recall D-0571-2025 was initiated by Cardinal Health Inc. on Jul 30, 2025 and is designated Class II. Reason for recall: CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements. The recall status is ongoing. Affected quantity: 6 units.

Recall details

Product Type
Drugs
Report Date
Aug 13, 2025
Initiation Date
Jul 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6 units

Product description

Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.

Reason for recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Distribution pattern

Nationwide Within the U.S.

Code information

Lot: 3617756, Expires: 12/31/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0571-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0571-2025. Report a data issue: hello@regdatalab.com.